Stockreport

Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference

Trevi Therapeutics, Inc.  (TRVI) 
PDF NEW HAVEN, Conn., June 18, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and [Read more]